HomeProductsBioactive CompoundsMetabolic EnzymesThrombinDabigatran Etexilate
Chemical structure of CAS 211915-06-9

Dabigatran Etexilate

CAS No.211915-06-9
MDL No.MFCD18385005
MFC34H41N7O5
MW627.70
InChI KeyKSGXQBZTULBEEQ-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.211915-06-9
Product NameDabigatran Etexilate
IrritantIrritant
Signal Word:Warning
HCode:H315-H319-H335
PCode:P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

The discovery of dabigatran etexilate.

Frontiers in pharmacology • Vol. 4 • 2013
PMID: 23408233PMC: PMC3569592DOI: 10.3389/fphar.2013.00012

New oral anticoagulants: comparative pharmacology with vitamin K antagonists.

Clinical pharmacokinetics • Vol. 52, Issue 2 • 2013
PMID: 23292752DOI: 10.1007/s40262-012-0030-9

Dabigatran acylglucuronide, the major human metabolite of dabigatran: in vitro formation, stability, and pharmacological activity.

Drug metabolism and disposition: the biological fate of chemicals • Vol. 38, Issue 9 • 2010
PMID: 20551237DOI: 10.1124/dmd.110.033696

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

Journal of thrombosis and haemostasis : JTH • Vol. 5, Issue 11 • 2007
PMID: 17764540DOI: 10.1111/j.1538-7836.2007.02748.x

Documentation

Similar Products